All Articles

As Singapore's non-bank lending space heats up, Bizcap unveils a lucrative loyalty program. Is this a game-changer for SME funding or just a costly gambit?

Industrial giants struggle to scale automation beyond pilot projects. A new CEO playbook from ASI, backed by millions of autonomous miles, offers a blueprint.

As Ottawa rolls out a new food strategy, Pamela Cox examines whether it can fix a broken system of soaring costs and deep-seated insecurity for millions.

For decades, patients with a rare autoimmune anemia faced a cycle of steroids and relapse. New data on a targeted therapy may finally offer a durable solution.

While firms spend billions on tech, a new book argues the biggest data breaches stem from leadership gaps and process failures. Is your boardroom the real front line?

As FIFA World Cup 2026 kicks off, Hisense is executing a masterclass in market disruption, using the global stage to redefine the TV landscape with RGB MiniLED.

A Korean materials firm just won a top Boeing award. We go beyond the press release to reveal how it’s fortifying global supply chains and reshaping Asia's aerospace hub.

A new financing vehicle aims to de-risk high-integrity carbon projects, but can this "carbon streaming" model unlock Central Asia's climate potential?

FCPT's latest acquisition seems minor, but it reveals a powerful strategy for navigating economic uncertainty by targeting essential, service-based real estate.

As hospitals face a ballooning $55B annual IT bill, Vizient's latest acquisition signals a major offensive to control costs beyond the traditional supply chain.

After a decade-long hiatus from major global partnerships and a recent financial overhaul, Oriflame is betting on spectacle. But is this a savvy brand revival or a costly distraction?

JAB's ~$1.8B sale of its final KDP stake isn't just an exit; it's a masterclass in capital reallocation towards a focused consumer brand empire.

A new FDA-designated device aims to filter a deadly protein from the blood of sepsis patients. Can this novel approach finally conquer a global health crisis?

Northfield shareholders face a July 10 deadline to pick cash or stock in a merger tied to a complex bank conversion set to reshape the NJ/NY banking landscape.

Amid market uncertainty, Vornado's $1.1B valuation deal for Park Avenue Plaza signals a bullish long-term view on New York City's trophy office space.

With a $20M Series A led by L Catterton, Dr. Muneeb Shah's REMEDY is disrupting skincare. Here's how accessible science is winning over consumers.

AM Best's recent 'Excellent' rating for Weston2038's notes is more than a headline. It's a vote of confidence in a hidden world of financial architecture.

Xeris Biopharma secures a new patent for its rare disease drug KEVEYIS until 2039, a strategic move to fend off generic competition and lock in revenue.

Chicago's Pure Lithium named a WEF Technology Pioneer, validating its disruptive lithium metal battery and a model that could upend global supply chains.

An $11.6M C-PACE deal is turning a vacant Dallas warehouse into a data center, revealing a key strategy for sustainable growth in the AI era.